Author Topic: Technology: Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises  (Read 570 times)

MikeLigalig.com

  • FOUNDER
  • Webmaster
  • *****
  • Posts: 33284
  • Please use the share icons below
    • View Profile
    • Book Your Tickets on a Budget
Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises

Shares of Novo Nordisk fell 14% and Sanofi rose 3.2% on Monday, a day after Novo announced that its challenger to Sanofi's leading drug has hit a roadblock. The Food and Drug Administration said it won't approve Novo's (NVO) long-acting insulin candidate degludec until it gets more data assessing the possible heart risks associated with the drug. This was a surprise since the FDA went beyond the recommendations that its advisory panel made in

Source: Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises

Linkback: https://tubagbohol.mikeligalig.com/index.php?topic=68698.0
John 3:16-18 ESV
For God so loved the world, that he gave his only Son (Jesus Christ), that whoever believes in him should not perish but have eternal life. For God did not send his Son into the world to condemn the world, but in order that the world might be saved through him. Whoever believes in him is not condemned, but whoever does not believe is condemned already, because he has not believed in the name of the only Son of God.

👉 GET easy and FAST online loan at www.tala.com Philippines

Book tickets anywhere for planes, trains, boats, bus at www.12go.co

unionbank online loan application low interest, credit card, easy and fast approval

Tags: